Shenzhen Winkey Pharmaceutical and ChemSpec Ltd enter into a new agreement for the US market

ChemSpec new agreement with Shenzhen Winkey Pharmaceutical

Shenzhen Winkey Pharmaceutical and Safic-Alcan are entering into an agreement in the US for the distribution of WKPep™ cosmetic peptides for the personal care markets. The territory scope of the contract is full national coverage representing Winkey in all 50 states.

WKPep™ cosmetic peptides are part of Winkey’s advanced scientific platform. They focus on new molecular structures and efficacious design for superior innovation. The team evaluates their cosmetic ingredients using in-vitro and in-vivo testing with absolutely no animal testing. Winkey’s research is carried out according to pharmaceutical standards with patented technologies developed throughout the years. Their peptides focus on skin care benefits including anti-aging, anti-inflammatory, moisturization and hyperpigmentation, as well as supporting multiple stages of follicle development for the hair care market.

We are thrilled to build a strategic partnership with ChemSpec, Ltd., member of Safic-Alcan Group in United States market, an excellent company with significant market expertise. The collaboration is an important milestone for Winkey to expand into the US market as well as be deeply involved into the international market. With the full support of Chemspec, Ltd, we are looking forward to greater achievements in US market.

We are very pleased with the opportunity to begin our partnership with Winkey, as they are a leader in innovation and active ingredients. This is an exciting new chapter where we get to support Winkey’s expansion and growth in the US market and bring innovative peptides to our customers as well. We look forward to growing together and strengthening the US proposition for both Winkey as well as ChemSpec Ltd. “ says Jacquelyn Ryan, Sales and Marketing Director, ChemSpec Ltd.

Popular post